A successful clean-tech pilot can provide compelling technical evidence. An investment decision also depends on how that evidence connects to buyers, procurement, economics and a repeatable commercial system.
The task is to establish what each document supports and what remains unresolved. A commercial-evidence register can make that distinction easier to review with management and an investment committee. It is a practitioner working aid, not a validated scoring system or an investment recommendation.
Five evidence categories
| Category | Question for the register |
|---|---|
| Technical performance | Under which conditions did the technology work, and what was measured? |
| Buyer decision | Who has authority, a reason to act and a plausible funding route? |
| Procurement acceptance | Which evidence has the actual buyer accepted, and for what next step? |
| Delivered economics | What do installation, service and risk allocation do to the economics? |
| Repeatability | What can another salesperson or partner execute without the founder? |
For each row, record the claim, the supporting document, who supplied it, the limitations and the next question. Separate observed facts from management assumptions. An unknown is a legitimate entry when the evidence has not been established.
Read commitments at their actual strength
A letter of intent, a paid trial and a repeat order can all be useful signals. They support different conclusions. Read the terms, authority and conditions behind each rather than grouping them under a single label such as commercial traction.
A paid pilot demonstrates that someone funded a test. Examine whether the sponsor has authority over the next purchase and whether that purchase follows the same budget route. A reference may demonstrate technical performance while being unsuitable for another buyer's procurement requirements.
These distinctions are especially useful when technical success has created justified confidence inside the team. Confidence can make an untested commercial assumption harder to notice; the register gives it a visible place to be examined.
Look beyond the headline margin
Delivered economics need the costs and responsibilities associated with the actual deployment model. Ask where application engineering, integration, commissioning, consumables, support and performance risk sit. Identify which figures are measured and which are assumptions.
A margin based on a product leaving the factory may answer a different question from the margin on a supported installation. The register should make that boundary explicit so the committee can decide what additional evidence matters. It does not need to manufacture false precision where the deployment history is still limited.
Examine the next sale
A founder may have secured the first buyer through exceptional technical knowledge, credibility or negotiation. Ask which parts can be carried by another employee or partner. Check the availability of accepted reference evidence, a usable offer, qualification criteria and defined responsibilities.
The next commercial milestone should follow the gap exposed by the evidence. It might be a reference accepted by a target buyer, a funded procurement step, a supported installation with credible cost data or a sale executed through the intended channel. A calendar target alone does not establish that any of those conditions exists.
Make the review actionable
End with a short list of unresolved commercial questions, the evidence needed to address each, and the management action that can obtain it. Keep the conclusion proportional to the material reviewed. A commercial review supports the wider decision process; it does not replace technical, legal or financial diligence.
Background and next step
The July 2026 field note The Commercialization Gap Investors Keep Underestimating explains why pilot performance and commercial readiness can diverge. The register above turns that distinction into a review structure.
For an investment team or portfolio review, explore the Investor Commercialization Risk Review. The existing program describes a written risk memo, scorecard, investment-committee-ready summary or presentation, and debrief. Scope, fees and the evidence required are agreed on enquiry.
Practitioner working aid by Arpad Talasi. The dated background analyses are linked in the text.